Glucose control with insulin results in reduction of NF‐κB‐binding activity in mononuclear blood cells of patients with recently manifested type 1 diabetes

Aim:  Chronic elevated blood glucose levels are associated with the formation of advanced glycation endproducts (AGEs). Hyperglycaemia and AGEs have been shown to induce activation of the redox‐sensitive transcription factor nuclear factor‐κB (NF‐κB). To validate the hypothesis that the maintenance of normal glucose levels results in the reduction of NF‐κB‐binding activity in vivo, the redox‐sensitive transcription factor NF‐κB was used as marker of hyperglycaemia‐induced mononuclear cell activation in patients who recently developed type 1 diabetes.

[1]  J. Suwaidi,et al.  Cardiovascular Surgery, Hamad General Hospital – Hamad Medical , 2022 .

[2]  J. Schneider,et al.  Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. , 2004, The Journal of clinical investigation.

[3]  T. Lyons,et al.  ‘Lipoproteins, glycoxidation and diabetic angiopathy’ , 2004, Diabetes/metabolism research and reviews.

[4]  D. Lackland,et al.  Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. , 2004, Investigative ophthalmology & visual science.

[5]  D. Bonnefont-Rousselot The Role of Antioxidant Micronutrients in the Prevention of Diabetic Complications , 2004, Treatments in endocrinology.

[6]  D. Lackland,et al.  Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. , 2003, Kidney international.

[7]  E. Ritz,et al.  Special characteristics of atherosclerosis in chronic renal failure. , 2003, Clinical nephrology.

[8]  Michael Stumvoll,et al.  Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs. , 2003, Diabetes.

[9]  John M. Lachin,et al.  Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. , 2003, JAMA.

[10]  Matthew D. Davis,et al.  Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. , 2002, JAMA.

[11]  M. Taskinen Diabetic dyslipidemia. , 2002, Atherosclerosis. Supplements.

[12]  P. Fasching,et al.  Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. , 2000, Diabetes.

[13]  J. Bastard,et al.  Consequences of the diabetic status on the oxidant/antioxidant balance. , 2000, Diabetes & metabolism.

[14]  I. West Radicals and oxidative stress in diabetes , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[15]  B. Isermann,et al.  Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. , 1999, Diabetologia.

[16]  J. Baynes,et al.  Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. , 1999, Diabetes.

[17]  B. Isermann,et al.  Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kB , 1999, Diabetologia.

[18]  T. Collins,et al.  The nuclear factor-kappa B/inhibitor of kappa B autoregulatory system and atherosclerosis. , 1998, Current opinion in lipidology.

[19]  T. Luther,et al.  Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. , 1997, Circulation.

[20]  T. Luther,et al.  Advanced Glycation End Product-Induced Activation of NF-κB is Suppressed by α-Lipoic Acid in Cultured Endothelial Cells , 1997, Diabetes.

[21]  D. Männel,et al.  Role of NFkappaB in the mortality of sepsis. , 1997, The Journal of clinical investigation.

[22]  E. Stadtman,et al.  Protein Oxidation in Aging, Disease, and Oxidative Stress* , 1997, The Journal of Biological Chemistry.

[23]  A. Schmidt,et al.  Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress* , 1997, The Journal of Biological Chemistry.

[24]  A. Schmidt,et al.  Characterization and Functional Analysis of the Promoter of RAGE, the Receptor for Advanced Glycation End Products* , 1997, The Journal of Biological Chemistry.

[25]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[26]  T. Luther,et al.  The Dietary Pigment Curcumin Reduces Endothelial Tissue Factor Gene Expression by Inhibiting Binding of AP-1 to the DNA and Activation of NF-κB , 1997, Thrombosis and Haemostasis.

[27]  R. Knuechel,et al.  Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. , 1996, The Journal of clinical investigation.

[28]  W. Kisiel,et al.  Mechanism of the Tumor Necrosis Factor α-mediated Induction of Endothelial Tissue Factor (*) , 1995, The Journal of Biological Chemistry.

[29]  A. Tamir,et al.  Commercial dialysate inhibits TNFα mRNA expression and NF-κB DNA-binding activity in LPS-stimulated macrophages , 1995 .

[30]  V. Mohan,et al.  Does oxidant stress play a role in diabetic retinopathy? , 1995, Indian journal of ophthalmology.

[31]  P. Baeuerle,et al.  Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.

[32]  T. Collins Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[33]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.